191 related articles for article (PubMed ID: 7999263)
1. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
3. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
Trempus CS; Haseman JK; Tennant RW
Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
[TBL] [Abstract][Full Text] [Related]
4. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice.
Hansen LA; Tennant R
Mol Carcinog; 1994 Mar; 9(3):143-54. PubMed ID: 7908201
[TBL] [Abstract][Full Text] [Related]
5. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
6. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
Spalding JW; Momma J; Elwell MR; Tennant RW
Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
[TBL] [Abstract][Full Text] [Related]
7. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.
Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW
Mol Carcinog; 2000 Jan; 27(1):24-33. PubMed ID: 10642434
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
9. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
10. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.
Smith MK; Trempus CS; Gilmour SK
Carcinogenesis; 1998 Aug; 19(8):1409-15. PubMed ID: 9744537
[TBL] [Abstract][Full Text] [Related]
11. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
[TBL] [Abstract][Full Text] [Related]
12. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
Sutter C; Strickland JE; Welty DJ; Yuspa SH; Winter H; Schweizer J
Mol Carcinog; 1991; 4(6):467-76. PubMed ID: 1724371
[TBL] [Abstract][Full Text] [Related]
13. Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA.
Thompson KL; Rosenzweig BA; Honchel R; Cannon RE; Blanchard KT; Stoll RE; Sistare FD
Mol Carcinog; 2001 Dec; 32(4):176-86. PubMed ID: 11746829
[TBL] [Abstract][Full Text] [Related]
14. Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions.
Aldaz CM; Trono D; Larcher F; Slaga TJ; Conti CJ
Mol Carcinog; 1989; 2(1):22-6. PubMed ID: 2499343
[TBL] [Abstract][Full Text] [Related]
15. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mouse skin tumorigenesis by dexamethasone occurs through a Ha-ras-independent mechanism.
Strawhecker JM; Pelling JC
Carcinogenesis; 1992 Nov; 13(11):2075-80. PubMed ID: 1423878
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.
Battalora MS; Spalding JW; Szczesniak CJ; Cape JE; Morris RJ; Trempus CS; Bortner CD; Lee BM; Tennant RW
Carcinogenesis; 2001 Apr; 22(4):651-9. PubMed ID: 11285202
[TBL] [Abstract][Full Text] [Related]
18. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
Hansen LA; Spalding JW; French JE; Tennant RW
Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
[TBL] [Abstract][Full Text] [Related]
19. Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression.
Wang XJ; Greenhalgh DA; Eckhardt JN; Rothnagel JA; Roop DR
Mol Carcinog; 1994 May; 10(1):15-22. PubMed ID: 8185825
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
